Group One Trading, L.P. Eye Point Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$3.03 - $9.0 $5,981 - $17,766	1,974 Added 21.64%	11,094 $96,000
Q1 2023 May 12, 2023	BUY	$2.28 - $5.04 $20,793 - $45,964	9,120 New	9,120 $26,000
Q3 2022 Nov 09, 2022	SELL	$6.96 - $11.12 $52,986 - $84,656	-7,613 Reduced 96.14%	306 $2,000
Q2 2022 Aug 11, 2022	SELL	$7.25 - $12.71 $1,109 - $1,944	-153 Reduced 1.9%	7,919 $62,000
Q1 2022 May 12, 2022	BUY	$8.67 - $14.11 $18,397 - $29,941	2,122 Added 35.66%	8,072 $98,000

Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $60,571 - $109,479	5,950 New	5,950 $73,000
Q3 2021 Nov 12, 2021	SELL	$7.51 - $11.72 $432,974 - $675,693	-57,653 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$8.69 - $11.08 $35,646 - $45,450	-4,102 Reduced 6.64%	57,653 $518,000
Q1 2021 May 12, 2021	BUY	$8.89 - $14.92 $474,539 - $796,414	53,379 Added 637.29%	61,755 $627,000
Q4 2020 Feb 10, 2021	BUY	$3.7 - $6.58 $30,991 - $55,114	8,376 New	8,376 $55,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.